1. Generics Bulletin
  2. >>Products
  3. >>Biosimilars

Alvotech And DKSH Extend Partnership For Six Biosimilars

Aim To Target Emerging Asian Markets

 
• By Akriti Seth

Alvogen sister company Alvotech is continuing to extend its network of commercial partners by expanding its partnership with DKSH, a Swiss market expansion services group, for the commercialization of six biosimilars in Asian markets.

Asia
With DKSH’s expertise in Asia, Alvotech plans to commercialize six more biosimilars • Source: Shutterstock

After partnering for adalimumab in 36 emerging countries in South-East Asia, Alvotech  and Swiss market expansion services group DKSH, have expanded their partnership to commercialize six more biosimilars in Asian markets.

The collaboration covers Taiwan, Korea, Hong Kong, the Philippines, Vietnam, Thailand, Cambodia, Myanmar, Malaysia, Singapore, Indonesia, India, Bangladesh and

More from Biosimilars

More from Products